Carlyle Group Inc. Vera Therapeutics, Inc. Transaction History

Carlyle Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$13.71 - $19.64 $13.4 Million - $19.2 Million	-978,682 Reduced 40.49%	1,438,155 $19.7 Million
Q2 2023 Aug 04, 2023	SELL	$6.11 - $17.83 $3.32 Million - $9.69 Million	-543,394 Reduced 18.36%	2,416,837 $38.8 Million
Q1 2023 May 05, 2023	BUY	$5.41 - $18.3 $16 Million - $54.2 Million	2,960,231 New	2,960,231 $23 Million

184

55.1M

134K

156K

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.31B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

Get notified when there are updates to the investment portfolio of Carlyle Group Inc., based on Form 13F filings with the SEC.

Stay updated on Carlyle Group Inc. with notifications on news.